Patents by Inventor Kayvon Pedram

Kayvon Pedram has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416377
    Abstract: Provided are bifunctional molecules that include a first moiety that specifically binds a cell surface molecule or extracellular molecule, and a second moiety that specifically binds a lysosomal targeting molecule. The bifunctional molecules find use, e.g., for targeted degradation of cell surface and extracellular molecules (e.g., proteins) via the endosomal/lysosomal pathway. Also provided are compositions and kits that include the bifunctional molecules, as well as methods of using the bifunctional molecules. Methods of making bifunctional molecules are also provided.
    Type: Application
    Filed: September 8, 2023
    Publication date: December 28, 2023
    Inventors: Carolyn R. Bertozzi, Steven Banik, Kayvon Pedram, Green Ahn
  • Patent number: 11787865
    Abstract: Provided are bifunctional molecules that include a first moiety that specifically binds a cell surface molecule or extracellular molecule, and a second moiety that specifically binds a lysosomal targeting molecule. The bifunctional molecules find use, e.g., for targeted degradation of cell surface and extracellular molecules (e.g., proteins) via the endosomal/lysosomal pathway. Also provided are compositions and kits that include the bifunctional molecules, as well as methods of using the bifunctional molecules. Methods of making bifunctional molecules are also provided.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: October 17, 2023
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Carolyn Bertozzi, Steven Banik, Kayvon Pedram, Green Ahn
  • Publication number: 20220023434
    Abstract: Provided are bifunctional molecules that include a first moiety that specifically binds a cell surface molecule or extracellular molecule, and a second moiety that specifically binds a lysosomal targeting molecule. The bifunctional molecules find use, e.g., for targeted degradation of cell surface and extracellular molecules (e.g., proteins) via the endosomal/lysosomal pathway. Also provided are compositions and kits that include the bifunctional molecules, as well as methods of using the bifunctional molecules. Methods of making bifunctional molecules are also provided.
    Type: Application
    Filed: December 18, 2019
    Publication date: January 27, 2022
    Inventors: Carolyn Bertozzi, Steven Banik, Kayvon Pedram, Green Ahn
  • Publication number: 20220025057
    Abstract: Provided are bifunctional molecules that include a first moiety that specifically binds a cell surface molecule or extracellular molecule, and a second moiety that specifically binds a lysosomal targeting molecule. The bifunctional molecules find use, e.g., for targeted degradation of cell surface and extracellular molecules (e.g., proteins) via the endosomal/lysosomal pathway. Also provided are compositions and kits that include the bifunctional molecules, as well as methods of using the bifunctional molecules. Methods of making bifunctional molecules are also provided.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 27, 2022
    Inventors: Carolyn Bertozzi, Steven Banik, Kayvon Pedram, Green Ahn
  • Publication number: 20220003777
    Abstract: The present disclosure provides compositions and methods involving the use of mucin-specific proteases for mucin-specific cleavage, labeling, and/or enrichment of mucin domain glycoproteins. Also provided are methods for the analysis of mucin-domain glycoproteins useful in glycomapping of mucin glycosites and their associated glycoforms. Provided compositions and methods are also useful for selective cleavage, release, and enrichment of mucins from cell and tissue samples, for the study of native mucin biology, and for the detection and analysis of mucins that are aberrantly expressed in various conditions, including cancer.
    Type: Application
    Filed: November 7, 2019
    Publication date: January 6, 2022
    Inventors: Carolyn R. Bertozzi, Stacy A. Malaker, Kayvon Pedram, Dayeon Shon